KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Amortizatization of Intangibles (2022 - 2026)

ClearPoint Neuro recorded quarterly Amortizatization of Intangibles of $504000.0 in Q1 2026, up 784.21% quarter-over-quarter from $57000.0 in Q2 2023.

ClearPoint Neuro's Amortizatization of Intangibles history runs 3 years deep, the most recent figure standing at $504000.0 for Q1 2026.

  • In Q1 2026, Amortizatization of Intangibles changed N/A year-over-year to $504000.0; the TTM figure through Mar 2026 stood at $504000.0 (changed N/A YoY), while the FY2025 annual figure was $168000.0, changed N/A from the prior year.
  • Amortizatization of Intangibles came in at $504000.0 for Q1 2026 at ClearPoint Neuro, up from $57000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $504000.0 in Q1 2026 to a low of $23000.0 in Q2 2022.
  • A 3-year average of $152333.3 and a median of $97000.0 in 2022 frame the typical range for Amortizatization of Intangibles.
  • On a YoY basis, Amortizatization of Intangibles climbed as much as 147.83% in 2023 and fell as far as 147.83% in 2023.
  • ClearPoint Neuro's Amortizatization of Intangibles stood at $125000.0 in 2022, then tumbled by 54.4% to $57000.0 in 2023, then soared by 784.21% to $504000.0 in 2026.
  • According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $504000.0, $57000.0, and $69000.0 for Q1 2026, Q2 2023, and Q1 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 422.00 Mn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 180.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 6.50 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 75.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 ClearPoint Neuro 375.84 Mn 340.24 Mn 7.76 Mn 504,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 504,000.00
Mar 31, 2026 504,000.00
Jun 30, 2023 57,000.00
Jun 30, 2023 57,000.00
Mar 31, 2023 69,000.00
Mar 31, 2023 69,000.00
Dec 31, 2022 125,000.00
Dec 31, 2022 125,000.00
Sep 30, 2022 136,000.00
Sep 30, 2022 136,000.00
Jun 30, 2022 23,000.00
Jun 30, 2022 23,000.00